|
A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
Research Funding - Specialised Therapeutics (Inst) |
|
|
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Specialised Therapeutics |
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Sanofi; Specialised Therapeutics |
|
|
Stock and Other Ownership Interests - Cochlear; Cochlear (I); CSL Limited; CSL Limited (I); ResMed; ResMed (I); Sirtex Medical; Sirtex Medical (I) |
Honoraria - GlaxoSmithKline; Sanofi |
Consulting or Advisory Role - Roche; Specialised Therapeutics |
Research Funding - Celgene (Inst); Genentech (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; Ipsen; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Specialised Therapeutics |
|
|
Consulting or Advisory Role - Specialised Therapeutics |
Travel, Accommodations, Expenses - Ipsen; Merck Serono |
|
|
Travel, Accommodations, Expenses - Merck |
|
Manju Dashini Chandrasegaram |
No Relationships to Disclose |
|
|
|
|
|
Research Funding - Abbott Diagnostics (Inst); Amgen (Inst); Australia & New Zealand Breast Cancer Trials Group (Inst); Australian Department of Health and Ageing (Inst); Australian Gastro-Intestinal Trials Group (Inst); Bayer (Inst); Bio-Based Industries (Inst); Bristol-Myers Squibb (Inst); Cancer Australia (Inst); Cancer Institute NSW (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); National Health and Medical Research Council (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst) |
Patents, Royalties, Other Intellectual Property - Specialised Therapeutics (Inst) |
|
|
Research Funding - Specialised Therapeutics (Inst) |
|
|
Research Funding - Celgene; Celgene (Inst) |